CD28-, CD45RAnull/dim and natural killer-like CD8+ T cells are increased in peripheral blood of women with low-grade cervical lesions

Table 1 HPV genotypes in patients with low-grade cervical lesions

Number of patients	Diagnosis	Age	HPV Infection		Patient’s number	Diagnosis	Age	HPV infection
			Low risk	High risk				Low risk	High risk
1	HPV-I	29		18	35	HPV-I	48		nd
2	HPV-I	34		nd	36	HPV-I	53		nd
3	HPV-I	23		nd	37	HPV-I	44		nd
4	HPV-I	24	6, 11	18	38	CIN-I	29		18
5	HPV-I	35		18	39	CIN-I	25		18
6	HPV-I	29		18	40	CIN-I	29		18
7	HPV-I	24		18	41	CIN-I	26		18
8	HPV-I	22		18	42	CIN-I	40		nd
9	HPV-I	32		18	43	CIN-I	35		18
10	HPV-I	21		18	44	CIN-I	27		18
11	HPV-I	23		18	45	CIN-I	24		18
12	HPV-I	35		18	46	CIN-I	25	6, 11	18
13	HPV-I	39		18	47	CIN-I	26		nd
14	HPV-I	34		18	48	CIN-I	22		nd
15	HPV-I	26		16,18	49	CIN-I	27	6, 11	18
16	HPV-I	23		18	50	CIN-I	29		nd
17	HPV-I	38		nd	51	CIN-I	37	6, 11	18
18	HPV-I	27		nd	52	CIN-I	35		18
19	HPV-I	34		18	53	CIN-I	31		18
20	HPV-I	26		nd	54	CIN-I	31		18
21	HPV-I	28		18	55	CIN-I	39		18
22	HPV-I	40		18	56	CIN-I	21		Negative
23	HPV-I	24		18	57	CIN-I	28		18
24	HPV-I	25	6, 11	18	58	CIN-I	35		nd
25	HPV-I	19	6, 11	18	59	CIN-I	40		nd
26	HPV-I	36		18	60	CIN-I	38		nd
27	HPV-I	20		nd	61	CIN-I	33		Nd
28	HPV-I	21		nd	62	CIN-I	41		Nd
29	HPV-I	24		nd	63	CIN-I	41		16,18
30	HPV-I	45		18	64	CIN-I	55		Negative
31	HPV-I	44		18	65	CIN-I	45		18
32	HPV-I	44		nd	66	CIN-I	43		18
33	HPV-I	45		Negative	67	CIN-I	55	6, 1.1	18
34	HPV-I	60		nd	68	CIN-I	41		Nd

ISSN: 1475-2867